Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Uncategorized
Prescription Drug STAR Act, Intended to Increase Drug Price Transparency,…
Recently, the House Ways & Means Committee unanimously passed the Prescription Drug Sunshine, Transparency, Accountability,…
Coalition of 44 States Files Antitrust Suit Against 20 Generic Companies…
Connecticut Attorney General William Tong along with 43 other State AG’s filed a lawsuit in the US District Court for the District…
Pharma Executives on Notice: Jury Convicts Insys Founder and Four Former…
On May 2, 2019, a federal jury convicted the founder and four former executives of Insys Therapeutics, Inc. (Insys) of a…
CBO Report: Prices for and Spending on Specialty Drugs in Medicare Part D…
A new Congressional Budget Office report Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid finds that net…
Growth Rate of Spending on Medicine Slows
The IQVIA Institute for Human Data Science recently released a report focused on net spending on medicines in the United States in…
NQP Playbook Released on Shared Decision Making in Health Care Settings
In March 2018, the National Quality Forum (NQF) released a guide for healthcare providers, the National Quality Partners…
Bernie Sanders Introduces Bill Imposing Jail Time for Pharma Execs
Vermont Senator and former Democratic presidential candidate Bernie Sanders introduced a bill into the United States Senate on…
The Insys Net Gets Wider
In mid-March 2018, five New York City doctors were arrested and charged with accepting bribes and kickbacks from Insys…
House E&C Subcommittee on Health Reviews Dozens of Opioid Bills
Last week, the House Energy and Commerce Subcommittee on Health held a two-day hearing entitled “Combating the Opioid Crisis:…
What Should I Consider Before Joining an APM?
As physician practices consider joining an alternative payment model (APM), Medical Economics published an interesting list of…